Given the incomplete response of TNF blockade to treat depression14, interleukin (IL)-6 blockade may be an effective strategy15,16 since IL-6 is reliably elevated in MDD17–22 and associated with induction of depression following inflammatory challenge13,14. Here, TNF is linked to depressive symptom measurement.